Blood Predictive Biomarkers for Patients With Non–small-cell Lung Cancer Associated With Clinical Response to Nivolumab

Published 2019 View Full Article

Authors

Keywords

Biochemical changes in tumor progression, Clinical efficacy, Immune checkpoint inhibitors, Non-invasive quantification of tumour biomarkers, Outcomes in immunotherapy-treated patients

Journal

Clinical Lung Cancer

Volume -, Issue -, Pages -

Publisher

Elsevier BV

Online

2019-08-31

DOI

10.1016/j.cllc.2019.08.006

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started